A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for haemorrhagic fever with renal syndrome delivered by intramuscular electroporation. [electronic resource]
Producer: 20141125Description: 110-7 p. digitalISSN:- 1469-0691
- Adolescent
- Adult
- Antibodies, Neutralizing -- blood
- Antibodies, Viral -- blood
- Electroporation
- Female
- Hantaan virus -- genetics
- Hemorrhagic Fever with Renal Syndrome -- prevention & control
- Humans
- Injections, Intramuscular
- Male
- Middle Aged
- Neutralization Tests
- Puumala virus -- genetics
- Vaccination
- Vaccines, DNA -- administration & dosage
- Viral Vaccines -- administration & dosage
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.